Molarium: Agent-Generated Adaptive Software for Molecular Design
- 1PsiThera
Abstract
Commercial drug discovery software has traditionally bundled three sources of value: the interface, the scientific models, and the specialized expertise required to run the models through the interface, thereby translating outputs into design decisions. Large language models, coding agents, and tool-using agents are beginning to unbundle this paradigm. Interfaces, analyses, workflow logic, and substantial portions of scientific software can increasingly be generated to meet the needs of a particular scientist, project, and question, while agents can automate sophisticated workflows that once required specialist users. This shift repositions where competitive advantage is created in computational drug discovery. More intuitive interfaces and faster execution alone do not fix model inaccuracies or broaden the applicability domain. As the underlying tooling becomes increasingly accessible and fluid, strategic differentiation will shift away from familiarity with a particular software package and toward superior preditive algorithms, more generalizable models, proprietary experimental data, accumulated discovery intelligence, and the human discernment needed to frame the right questions and evaluate the answers. Molarium, available at https://molarium.org , provides a case study of this transition in the context of molecular design software. Created during an intensive weekend effort of a tireless drug-discovery scientist and an AI coding agent, this open-source molecular workbench operates exclusively in a standard web browser. It integrates local molecular graphics, editing, conformer generation, energy minimization, molecular dynamics, machine-learned potentials, and protein-structure prediction workflows. Beneath its rapidly adaptable interface, Molarium maintains a versioned molecular state together with user actions, method specifications, provenance, and validation evidence. Decoupling an adaptable interface from an enduring scientific core points toward a broader architecture for generated adaptive software in drug discovery.
Related
- Polymer Network Engineering of Hydrogel Bioinks for Skin Regeneration: From Molecular Design to Adaptive Biofabrication
- Chemistry of adaptive polymer-based protective coatings for harsh environments: chemical aging, anticorrosion, antifouling, and self-healing design
- Adaptive Catalytic Interfaces for Biomass-Derived Model Compounds: Dynamic Active Sites, Microenvironments, and Operando-Guided Design
- Cheminformatics as a core driver of molecular discovery and design
- Tissues As a Synthetic Target – A Framework For the Multiscale Molecular Design Of Thermogelling Polymers
BibTeX
@misc{wiewiora2026molarium,
title = {{Molarium: Agent-Generated Adaptive Software for Molecular Design}},
author = {Rafal Wiewiora and Woody Sherman},
howpublished = {ChemRxiv},
year = {2026},
month = sep,
doi = {10.26434/chemrxiv.15008528/v1},
url = {https://chemrxiv.org/doi/full/10.26434/chemrxiv.15008528/v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Molarium: Agent-Generated Adaptive Software for Molecular Design
AU - Rafal Wiewiora
AU - Woody Sherman
PY - 2026
DA - 2026/09/08
PB - ChemRxiv
DO - 10.26434/chemrxiv.15008528/v1
UR - https://chemrxiv.org/doi/full/10.26434/chemrxiv.15008528/v1
AB - Commercial drug discovery software has traditionally bundled three sources of value: the interface, the scientific models, and the specialized expertise required to run the models through the interface, thereby translating outputs into design decisions. Large language models, coding agents, and tool-using agents are beginning to unbundle this paradigm. Interfaces, analyses, workflow logic, and substantial portions of scientific software can increasingly be generated to meet the needs of a particular scientist, project, and question, while agents can automate sophisticated workflows that once required specialist users. This shift repositions where competitive advantage is created in computational drug discovery. More intuitive interfaces and faster execution alone do not fix model inaccuracies or broaden the applicability domain. As the underlying tooling becomes increasingly accessible and fluid, strategic differentiation will shift away from familiarity with a particular software package and toward superior preditive algorithms, more generalizable models, proprietary experimental data, accumulated discovery intelligence, and the human discernment needed to frame the right questions and evaluate the answers. Molarium, available at https://molarium.org , provides a case study of this transition in the context of molecular design software. Created during an intensive weekend effort of a tireless drug-discovery scientist and an AI coding agent, this open-source molecular workbench operates exclusively in a standard web browser. It integrates local molecular graphics, editing, conformer generation, energy minimization, molecular dynamics, machine-learned potentials, and protein-structure prediction workflows. Beneath its rapidly adaptable interface, Molarium maintains a versioned molecular state together with user actions, method specifications, provenance, and validation evidence. Decoupling an adaptable interface from an enduring scientific core points toward a broader architecture for generated adaptive software in drug discovery.
ER -